PDCD1 and ovarian cancer: Advanced solid tumours for which standard therapy is no longer effective or does not exist (including ovarian cancer).AO-176 alone or in combination with paclitaxel or Pembrolizumab (anti-PD1 mAb).Non-randomised, open-label.